• Title/Summary/Keyword: Steven-Johnson syndrome

Search Result 3, Processing Time 0.018 seconds

Early surgical correction of microstomia following Stevens-Johnson syndrome

  • Ki, Sae Hwi;Jo, Gang Yeon;Ma, Sung Hwan;Choi, Matthew Seung Suk
    • Archives of Craniofacial Surgery
    • /
    • v.21 no.2
    • /
    • pp.119-122
    • /
    • 2020
  • Stevens-Johnson syndrome (SJS) is a rare disease in which extensive toxic epidermolysis occurs after medication. Skin and mucous membranes are involved in about 90% of SJS cases, and webbing of mouth corners (microstomia) may occur when they are affected. Few reports have been issued on microstomia in SJS, and no consensus has been reached regarding treatment methods, timings, or results. We encountered a case of microstomia following SJS after ofloxacin medication in a 22-year-old woman treated by commissuroplasty using a lozenge-shaped excision. We present an appropriate correction method and surgical timing for microstomia following SJS.

Oral management of Stevens-Johonson syndrome, toxic epidermal necrolysis patients (스티븐 존슨 증후군과 중독성 표피 괴사 융해증 환자의 구강위생관리)

  • Park, Ji-Il;Yoon, Seon-Hack
    • Journal of Korean society of Dental Hygiene
    • /
    • v.8 no.4
    • /
    • pp.31-41
    • /
    • 2008
  • Steven-Johnson syndrome (SJS) and toxic epidermal necrolysis(TEN) are severe mucocutaneous reaction which are most frequently caused by drugs. Although the incidence of SJS and TEN is known to be relatively low, outcomes may be fatal. A systematic approach is required because morbidity rate is currently increasing and oral lesion is frequent. We investigated the clinical features and outcomes of 6 patients diagnosed as SJS and TEN and referred from the department of dermatology, Chonnam National University Hospital for oral care. Ketoconazol, Ofloxacin, Chlorphenesin, Amoxicillin, Pontal, Harnal, and Ciprofloxacin were suspected as the causative drugs. Average treatment period was 3.2 weeks, and two patients were referred to 'burn-patients' hospital. Most of oral lesion were cured be normal tissue, but scares with discoloration were observed. For intraoral management, antibiotic disinfection and steroid application were performed according to systemic treatment principles. Additionally, ingestion of zinc, antioxidants, and vitamin was recommended. The establishment of oral treatment principles is demanded because it has not been yet. Also, through investigation of drug side effect and careful prescription are required.

  • PDF

Two cases of central nervous system complications caused by Mycoplasma pneumoniae infection (Mycoplasma pnuemonia 감염에 의한 중추신경계 합병증 2례)

  • Kim, Shin Mi;Heo, Ji Seung;Shim, Eun Jung;Lee, Dae Hyoung;Cho, Do Jun;Kim, Dug Ha;Min, Ki Sik;Yoo, Ki Yang
    • Clinical and Experimental Pediatrics
    • /
    • v.51 no.5
    • /
    • pp.533-537
    • /
    • 2008
  • Mycoplasma pneumoniae (M. pneumoniae) infection causes a wide variety of clinical manifestations in children and young adults, the main one being pneumonia. M. pneumoniae is transmitted from person to person by infected respiratory droplets. Symptoms caused by M. pneumoniae infection can be divided into those involving the respiratory tract, and those caused by extrapulmonary disease. M. pneumoniae infections may cause central nervous system (CNS) complications-with encephalitis being the most frequent-and stroke being a rare complication. The pathogenesis of the CNS disease is unclear; possibilities include direct infection and an immune-mediated reaction. We present two cases of CNS complications subsequent to infection with M. pneumoniae; both cases had convincing evidence of preceding M. pneumoniae respiratory disease with no evidence of viable M. pneumoniae in the cerebrospinal fluid. We report cases of encephalitis and stroke following a recent M. pneumoniae infection.